P24521
Gene name |
ERG8 |
Protein name |
Phosphomevalonate kinase |
Names |
|
Species |
Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast) |
KEGG Pathway |
sce:YMR220W |
EC number |
2.7.4.2: Phosphotransferases with a phosphate group as acceptor |
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for P24521
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-P24521-F1 | Predicted | AlphaFoldDB |
21 variants for P24521
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| s13-712384 | 24 | T>P | No | SGRP | |
| s13-712460 | 49 | G>E | No | SGRP | |
| s13-712538 | 75 | S>T | No | SGRP | |
| s13-712618 | 102 | K>E | No | SGRP | |
| s13-712632 | 106 | D>E | No | SGRP | |
| s13-712635 | 107 | D>E | No | SGRP | |
| s13-712646 | 111 | R>T | No | SGRP | |
| s13-712717 | 135 | R>C | No | SGRP | |
| s13-712888 | 192 | A>S | No | SGRP | |
| s13-713011 | 233 | I>V | No | SGRP | |
| s13-713023 | 237 | T>S | No | SGRP | |
| s13-713044 | 244 | H>Y | No | SGRP | |
| s13-713053 | 247 | D>N | No | SGRP | |
| s13-713062 | 250 | D>N | No | SGRP | |
| s13-713101 | 263 | G>R | No | SGRP | |
| s13-713467 | 385 | Q>E | No | SGRP | |
| s13-713536 | 408 | T>A | No | SGRP | |
| s13-713561 | 416 | A>D | No | SGRP | |
| s13-713572 | 420 | N>D | No | SGRP | |
| s13-713636 | 441 | K>R | No | SGRP | |
| s13-713659 | 449 | L>F | No | SGRP |
No associated diseases with P24521
Functions
| Description | ||
|---|---|---|
| EC Number | 2.7.4.2 | Phosphotransferases with a phosphate group as acceptor |
| Subcellular Localization |
|
|
| PANTHER Family | ||
| PANTHER Subfamily | ||
| PANTHER Protein Class | ||
| PANTHER Pathway Category | No pathway information available | |
3 GO annotations of cellular component
| Name | Definition |
|---|---|
| cytoplasm | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| nucleus | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
| peroxisome | A small organelle enclosed by a single membrane, and found in most eukaryotic cells. Contains peroxidases and other enzymes involved in a variety of metabolic processes including free radical detoxification, lipid catabolism and biosynthesis, and hydrogen peroxide metabolism. |
2 GO annotations of molecular function
| Name | Definition |
|---|---|
| ATP binding | Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator. |
| phosphomevalonate kinase activity | Catalysis of the reaction: (R)-5-phosphomevalonate + ATP = (R)-5-diphosphomevalonate + ADP + H(+). |
4 GO annotations of biological process
| Name | Definition |
|---|---|
| ergosterol biosynthetic process | The chemical reactions and pathways resulting in the formation of ergosterol, (22E)-ergosta-5,7,22-trien-3-beta-ol, a sterol found in ergot, yeast and moulds. |
| farnesyl diphosphate biosynthetic process, mevalonate pathway | The pathway that converts acetate, in the form of acetyl-CoA, to farnesyl diphosphate (FPP) through a series of mevalonate intermediates. Farnesyl diphosphate is an important substrate for other essential pathways, such as biosynthesis of sterols. |
| isopentenyl diphosphate biosynthetic process, mevalonate pathway | The chemical reactions and pathways resulting in the formation of isopentenyl diphosphate, via the intermediate mevalonate. This pathway converts acetate, in the form of acetyl-CoA, to isopentenyl diphosphate (IPP), the fundamental unit in isoprenoid biosynthesis, through a series of mevalonate intermediates. |
| organic acid phosphorylation | The process of introducing one or more phosphate groups into an organic acid. |
No homologous proteins in AiPD
| UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
|---|---|---|---|---|
| No homologous proteins | ||||
| 10 | 20 | 30 | 40 | 50 | 60 |
| MSELRAFSAP | GKALLAGGYL | VLDTKYEAFV | VGLSARMHAV | AHPYGSLQGS | DKFEVRVKSK |
| 70 | 80 | 90 | 100 | 110 | 120 |
| QFKDGEWLYH | ISPKSGFIPV | SIGGSKNPFI | EKVIANVFSY | FKPNMDDYCN | RNLFVIDIFS |
| 130 | 140 | 150 | 160 | 170 | 180 |
| DDAYHSQEDS | VTEHRGNRRL | SFHSHRIEEV | PKTGLGSSAG | LVTVLTTALA | SFFVSDLENN |
| 190 | 200 | 210 | 220 | 230 | 240 |
| VDKYREVIHN | LAQVAHCQAQ | GKIGSGFDVA | AAAYGSIRYR | RFPPALISNL | PDIGSATYGS |
| 250 | 260 | 270 | 280 | 290 | 300 |
| KLAHLVDEED | WNITIKSNHL | PSGLTLWMGD | IKNGSETVKL | VQKVKNWYDS | HMPESLKIYT |
| 310 | 320 | 330 | 340 | 350 | 360 |
| ELDHANSRFM | DGLSKLDRLH | ETHDDYSDQI | FESLERNDCT | CQKYPEITEV | RDAVATIRRS |
| 370 | 380 | 390 | 400 | 410 | 420 |
| FRKITKESGA | DIEPPVQTSL | LDDCQTLKGV | LTCLIPGAGG | YDAIAVITKQ | DVDLRAQTAN |
| 430 | 440 | 450 | |||
| DKRFSKVQWL | DVTQADWGVR | KEKDPETYLD | K |